Telemetry Investments’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Telemetry Investments’s Portfolio SCLN Stock Details SCLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-22,000	Closed	-$246K	–	170
2017 Q3	$246K	Buy	22,000 +10,000	+83%	+$110K	0.09%	114
2017 Q2	$132K	Buy	+12,000	New	+$120K	0.06%	109

Telemetry Investments's SCLN Position: Q4 2017 in Review

Telemetry Investments sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 22,000 shares — an estimated $246K sold.

Telemetry Investments first reported a position in SCLN in Q2 2017 and held it in 2 quarters. The position peaked at $246K in Q3 2017. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

Telemetry Investments reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
Telemetry Investments sold 22,000 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $246K.
Telemetry Investments first reported a position in Sciclone Pharmaceuticals Inc in Q2 2017 and held it in 2 quarters.
Telemetry Investments's Sciclone Pharmaceuticals Inc position peaked at $246K in Q3 2017.
0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on Telemetry Investments's 13F filing for Q4 2017, filed 14 Feb 2018.